RVM
MIRM icon

RiverVest Venture Management’s Mirum Pharmaceuticals MIRM Stock Holding History

RiverVest Venture Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,621,118
Closed -$41.9M – 6
2023
Q2 		$41.9M Hold
1,621,118
– – 46.52% 1
2023
Q1 		$38.9M Hold
1,621,118
– – 45.05% 1
2022
Q4 		$31.6M Sell
1,621,118
-300,000
-16% -$5.93M 36.87% 2
2022
Q3 		$40.4M Hold
1,921,118
– – 46.86% 1
2022
Q2 		$37.4M Hold
1,921,118
– – 54.94% 1
2022
Q1 		$42.3M Hold
1,921,118
– – 43.43% 1
2021
Q4 		$30.6M Hold
1,921,118
– – 21.86% 2
2021
Q3 		$38.3M Hold
1,921,118
– – 6.43% 2
2021
Q2 		$33.2M Hold
1,921,118
– – 6.49% 2
2021
Q1 		$38.1M Hold
1,921,118
– – 5.86% 2
2020
Q4 		$33.5M Buy
+1,921,118
New +$37.8M 3.68% 3

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return